INS and diabetes mellitus: Recent clinical trials indicated that agents which interrupt the renin-angiotensin axis such as enalapril reduce the risk of developing diabetes compared with other classes of antihypertensive drugs and blockage of the effects of angiotensin II might improve the blood pressure and the rate of blood flow to insulin-sensitive tissues [43].